Concern Foundation's Scientific Review

Los Angeles, CA: Next weekend (April 27th-28th, 2018), Concern Foundation will be holding it's biennial scientific review of the most recent grant proposals from new researchers. The grant period is for 2 years and there are an average of 15 recipients, each grant cycle.

What is The Scientific Review?
The Concern Foundation’s biennial Scientific Review is the process that determines which researchers receive Concern’s $60,000 Conquer Cancer Now Awards, and essentially, where all the money we raise goes.

Every two years, Concern flies in top researchers from all over the world who spend a weekend in Los Angeles for a rigorous process of reviewing the best of the best research applications that have been whittled down from nearly 200 cancer research applications that were received beginning in mid-September. These finalists will receive the Conquer Cancer Now Award. Concern Foundation has funded over 700 researchers through the Conquer Cancer Now Awards.

Why Do You Need a Scientific Committee Review to Decide Who Receives a Grant?
We believe in transparency. In order to be transparent in our grant selection and fund disbursement, we have a longstanding unbiased scientific review committee. This Scientific “Peer” Review is a process that actually has very little to do with us at Concern so that the awards are truly given to the next generation of young and innovative cancer research scientists based solely on the merits of their proposal.

Who Is on The Scientific Committee?
There are approximately 20 established researchers from major cancer research institutions who join us from various parts of the world (such as Sweden and Israel) and all over the US. The scientists that regularly attend include Dr. George Klein from The Karolinska Institute in Stockholm, Sweden, who previously served on the Nobel Prize Committee. Most all of the scientific review committee scientists are prior recipients of the Conquer Cancer Now Award who have made great advances in their field and continue to sit on the committee to help fund the next big idea in cancer research.